ANALYTE SENSING VIA ACRIDINE-BASED BORONATE BIOSENSORS

• US 20050191761A1
• Filed: 09/12/2001
• Published: 09/01/2005
• Est. Priority Date: 09/12/2001
• Status: Active Grant

• Current Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Minimed Incorporated (Medtronic Plc)
• Inventors: Van Antwerp, William P., Walsh, Joseph C., Noronha, Glenn, Ponder, Bill C., Heiss, Aaron M., Vachon, David J., Reilly, Jonathan
• Granted Patent: US 7,045,361 B2
• Time in Patent Office: Days
• US Class Current: 436/518
• CPC Class Codes: C12Q 1/54 involving glucose or galactose
• CPC Class Codes: G01N 33/66 involving blood sugars, e.g. galactose
• CPC Class Codes: Y10T 436/144444 Glucose

Abstract

Fluorescent biosensor molecules, fluorescent biosensors and systems, as well as methods of making and using these biosensor molecules and systems are described. These biosensor molecules address the problem of obtaining fluorescence emission at wavelengths greater than about 500 nm. Biosensor molecules generally include an (1) an acridine-based fluorophore, (2) a linker moiety and (3) a boronate substrate recognition/binding moiety, which binds polyhydroxylate analytes, such as glucose. These biosensor molecules further include a “switch” element that is drawn from the electronic interactions among these submolecular components. This fluorescent switch is generally “off” in the absence of bound polyhydroxylate analyte and is generally “on” in the presence of bound polyhydroxylate analyte. Thus, the reversible binding of a polyhydroxylate analyte essentially turns the fluorescent switch “on” and “off”. This property of the biosensor molecules, as well as their ability to emit fluorescent light at greater than about 500 nm, renders these biosensor molecules particularly well-suited for detecting and measuring in-vivo glucose concentrations.

Claims

1. A biosensor molecule, The biosensor molecule comprising:

an acridine-based fluorophore;

a boronate binding moiety that is capable of specifically and reversibly binding a polyhydroxylate analyte in a sample; and

a linker moiety that links the fluorophore to the boronate binding moiety, wherein the biosensor molecule is capable of emitting a light signal in the visible to near infrared region of the spectrum that can be correlated to a polyhydroxylate analyte concentration in a sample and further wherein the biosensor molecule comprises a molecule of the formula;

wherein

F is an acridine-based fluorophore;

R¹ is selected from the group consisting of hydrogen, and aromatic moieties;

R² and R⁴ are optional moieties selected from the group consisting of hydrogen, aliphatic and aromatic moieties and groups that are capable of forming covalent bonds to a biocompatible matrix;

L¹ and L² are —

CH₃—

;

Z is nitrogen;

R³ is an optional group selected from the group consisting of hydrogen, aliphatic and aromatic moieties and groups that are capable of forming covalent bonds to a biocomparible matrix; and

wherein F and Z are capable of being involved in an intramolecular photo-induced electron transfer process that quenches the fluorescence of F in the absence of bound polyhydroxylate analyte.

2. The biosensor molecule of claim 1, wherein the biosensor molecule emits light at about 500 nm or longer.

3. The biosensor molecule of claim 1, wherein the polyhydroxylate analyte is glucose.

5. The biosensor molecule of claim 1, wherein the acridine-based boronate biosensor molecule has at least one maximum wavelength in an emission spectrum of the biosensor molecule which is greater than about 420 nm.

6. The biosensor molecule of claim 5, wherein the acridine-based boronate biosensor molecule has at least one emission wavelength that is greater than about 450 nm with an intensity that is at least 25 percent of the intensity of a wavelength of a maximum intensity in the emission spectrum.

7. The biosensor molecule of claim 1, wherein the acridine-based boronate biosensor molecule is attached to a polymer matrix.

8. The biosensor molecule of claim 1, wherein the acridine-based fluorophore has at least one maximum wavelength in an emission spectrum of the biosensor which is between about 420 nm and about 750 nm.

9. The biosensor molecule of claim 1, wherein the acridine-based fluorophore is acridine orange.

10. The biosensor molecule of claim 2, wherein R³ includes a hydroxyl or an amine functional group.

11. The biosensor molecule of claim 10, wherein the hydroxyl or amine functional group includes and aliphatic linker with 2 or more carbon atoms.

12. The biosensor molecule of claim 1, wherein the acridine-based fluorophore further includes one or more moieties selected from the group consisting of at least an aliphatic group, an aromatic group, a haloalkane, an alcohol, an ether, an amine, an aldehyde, a ketone, an ester, a carboxylic acid, a sulfonic acid, a cyano group and a phosphoric acid.

21. An acridine-based fluorescent biosensor system for measuring in-vivo levels of a polyhydroxylate analyte, the biosensor system comprising:

the acridine-based fluorescent biosensor molecule of claim 1 attached to, or contained within, a polymer matrix to form the biosensor of the biosensor system;

an optical light source; and

a detector which detects a fluorescent signal, wherein the signal correlates to the in-vivo levels of the polyhydroxylate analyte.

46. An implantable biosensor, the biosensor comprising, the acridine-based biosensor molecule of claim 1 contained in a polymer matrix.

47. The implantable biosenor of claim 46, wherein the polymer matrix is biocompatible and water-soluble.

48. The implantable biosensor of claim 47, wherein the water-soluble polymer matrix is selected from polyethylene glycol (amino-terminated), polyethylene glycol hydroxy terminated), Jeffamine polymers (2-propyl amino terminated block-polypropylene oxide block-polyethylene oxide block-polypropylene oxide), poly(vinyl alcohol), poly(acrylic acid), and mixtures of these polymers.

49. The implantable biosensor of claim 46, wherein tie biosensor is contained in a biocompatible, water-insoluble material that is permeable to the polyhydroxylate analyte.

50. The biosensor of claim 49, wherein the water-insoluble material is selected from polyesters of carbonic acid, poly(vinylchloride), polyamides, polychloroethers, poly(urethanes, poly(imides) and mixtures of these materials.

51. The biosensor of claim 46, wherein the polymer matrix is a multiple attachment-point polymer.

52. The biosensor of claim 51, wherein the multiple attachment-point polymer is selected from at least cross-linked poly(vinyl alcohol), cross-linked poly(acrylic acid), stat dendrimers and mixtures of these polymers.

53. The biosensor of claim 46, wherein the polymer matrix is polycarboxystyrene.

54. The biosensor of claim 46, wherein the polymer matrix includes a blend of polymers selected to affect the pH and/or solubility of the environmental milieu surrounding the acridine-based biosensor molecule.

4. (canceled)

13-20. -20. (canceled)

22-45. -45. (canceled)